Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Clovis Oncology (CLVS)

Add to Watchlists
Create an Alert
53.50 -1.52  -2.76% NASDAQ Apr 23, 8:00PM BATS Real time Currency in USD
View Full Chart
CLVS Price Chart
View All Events

CLVS Events

Date Type Description
Feb 27 Misc Clovis Oncology Inc Q4 2013 Earnings Conference Call
Feb 27 Earnings Clovis Oncology Inc Q4 2013 Earnings Results. Estimate: -0.75.
Jan 13 Misc Clovis Oncology Announces 2014 Objectives and Financial Guidance
Oct 31 Misc Q3 2013 Clovis Oncology, Inc. Earnings Conference Call
Oct 31 Earnings Q3 2013 Clovis Oncology, Inc. Earnings Release. Estimate: -0.63.
Aug 01 Misc Clovis Oncology to Announce Second Quarter 2013 Financial Results and Host Webcast Conference Call on August 1
Aug 01 Earnings Q2 2013 Clovis Oncology, Inc. Earnings. Estimate: -0.68.
May 07 Misc Q1 2013 Clovis Oncology, Inc. Earnings Conference Call
May 07 Earnings Clovis Oncology Inc First Quarter Earnings Results. Estimate: -0.60.
View All Performance Charts

CLVS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Clovis Oncology is up 62.88% over the last year vs S&P 500 Total Return up 22.59%, Idera Pharmaceuticals up 439.5%, and Dendreon down 42.00%.

Get Quote for

PDF Report for CLVS

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download CLVS Pro Report PDF
Advertisement

Portfolio Strategies Featuring CLVS

Did Clovis Oncology make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

CLVS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Colorado
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Clovis Oncology Inc is a biopharmaceutical company. The Company is engaged in acquiring, developing and commercializing anti-cancer treatments in the United States, Europe and other international markets.

Recent Quotes

Symbol Price Chg Chg % Market Cap
CLVS 53.50 -1.52 -2.76% 1.813B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.